Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy

Running, not enrolling · Not applicable

Conditions studied: Glioma, Radiation Therapy Patient

In brief

This trial studies the feasibility of monitoring step count as a measure of physical activity in patients with newly diagnosed glioma undergoing radiation therapy. Physical activity measured by step count may help to improve the quality of life and symptoms for patients with newly diagnosed glioma.

Key facts

Study ID

NCT04186832

Run by

M.D. Anderson Cancer Center

People needed

50

Starts

2020-09-28

Expected to finish

2027-12-31

Last updated by the study team

2026-02-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with a glioma and going to receive at least 4 weeks of RT at MDACC at the Texas Medical Center campus with at least 20 fractions
• Karnofsky performance status (KPS) of 70 or above
• Wearable activity tracker (WAT) - naive
• Able to read and speak English
• Able to provide informed consent
• Access to a smartphone
• Access to Wi-Fi

You may not qualify if…

• Cognitive and/or major sensory deficits that would impede the completion of assessment instruments as deemed by the clinical team

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.